This journal is a peer reviewed, open access journal.
All articles published open access will be immediately and permanently free for everyone to read, download, copy and distribute. Permitted reuse is defined by the following user license:Creative Commons Attribution-NonCommercial-NoDerivs (CC BY-NC-ND): for non-commercial purposes, lets others distribute and copy the article, and to include in a collective work (such as an anthology), as long as they credit the author(s) and provided they do not alter or modify the article.
If you need to comply with your funding body policy you can apply for a CC BY license after your manuscript is accepted for publication.Open Access Publication Fee
As an open access journal with no subscription charges, a fee is payable by the author or research funder to cover the costs associated with publication. This ensures your article will be immediately and permanently free to access by everyone. The open access publication fee for this journal is EUR 1494 for Original Research Articles and Review Articles, EUR 556 for Short Format Articles, excluding taxes.There is a 30% discount off the open access publication fee for members of the European SocieTy for Radiotherapy & Oncology (ESTRO). Prices are listed below.
|Full Price||Society Member Price*|
|Original Research Articles and Review Articles||EUR 1450||EUR 1015|
|Short Format Articles||EUR 540||EUR 378|
* To be eligible for the society member discount the corresponding author must be a member of the European SocieTy for Radiotherapy & Oncology (ESTRO). To claim the discount the author can verify their membership at article submission stage. Elsevier reserves the right to remove or refuse the discount.
Funding Body AgreementsElsevier has established agreements with funding bodies, including Wellcome Trust and Research Councils UK. This ensures authors can comply with funding body open access policies and may also be reimbursed for their publication fees.
Author RightsFor open access publishing this journal uses an exclusive licensing agreement. Authors will retain copyright alongside scholarly usage rights and Elsevier will be granted publishing and distribution rights.
This journal publishes 12 issues a year.